StreetAlpha.app
Home › Stocks › PFE

Pfizer Inc (PFE)

Healthcare
$28.46
▼ −1.39%
LAST CLOSE · NOV 17

Pfizer is a pharmaceutical and biotechnology company based in New York that develops and sells medicines and vaccines. It last closed at $28.46 on Nov 17, down 1.39% on the day. PFE reports earnings on Tue, Feb 2, 2027. The average 12-month price target from 9 analysts is $30.89 (+8.5% from the last close), with a high of $35.00 and a low of $28.00. Analyst consensus is Hold, based on the latest ratings from 9 firms (3 buy, 6 hold, 0 sell). Over the past 90 days StreetAlpha recorded 3 whale options trades in PFE, 33% of them bullish and 67% bearish. In the past 30 days there were 32 dark pool prints totaling $34.4M, the largest $4.8M.

AI Auto Pilots
Is PFE in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$63.6B
+1.3% vs a year ago
Net income
$4.0B
−59.0% vs a year ago
EPS (diluted)
$0.70
−59.3% vs a year ago
Free cash flow
$11.8B
18.5% margin
Valuation
Market cap
$162B
5.70B shares
P/E
40.7
Price over 12 month EPS
Price to sales
2.5
Market cap over revenue
Dividend yield
6.04%
$1.72 a share over 12 months
Balance sheet
Cash & equivalents
$1.8B
At Sep 27
Debt
$62.6B
At Sep 27
Shareholder equity
$89.0B
Shares outstanding
5.70B
At Oct 28
CEOAlbert Bourla
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $81.3B$81.3BFY2021FY2022: $101B$101BFY2022FY2023: $59.6B$59.6BFY2023FY2024: $63.6B$63.6BFY2024FY2025: $62.6B$62.6BFY2025

From PFE's SEC filings, latest 10-Q for the period ending Sep 27, 2026 (filed Nov 3). Last 12 months adds up the four latest quarters.

Next report
Feb 2
2027 · Time not announced
Consensus EPS forecast
$0.69
$17.22B revenue est.
Year-ago EPS
$0.66
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Hold
Based on 9 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
9firms
3 Buy6 Hold0 Sell
Each firm's latest rating on PFE in the past 90 days
Average 12-month target
$30.89
▲ 8.5% upside

Based on 9 analysts who set a price target on PFE in the past 90 days. The average target is $30.89, with a high of $35.00 and a low of $28.00, compared with the last close of $28.46.

$23$27$32$36PAST 112 TRADING DAYS12-MONTH TARGETSHIGH $35AVG $30.89LOW $28May 22LAST CLOSE+12 MO$23$27$32$36PAST 112 DAYSTARGETSHIGH $35AVG $30.89LOW $28May 22LAST CLOSE+12 MO
Highest target$35.00
Average target$30.89
Lowest target$28.00
Latest rating changes
Freedom BrokerMaintained
Nov 7Buy$34
GuggenheimTarget raised
Nov 5Buy$31 → $33
UBSMaintained
Nov 4Hold$30
ScotiabankTarget raised
Nov 4Buy$33 → $35
CitigroupMaintained
Nov 4Hold$30
DateFirmActionRatingPrice target
Nov 7Freedom BrokerMaintainedBuy$34
Nov 5GuggenheimTarget raisedBuy$31 → $33
Nov 4UBSMaintainedHold$30
Nov 4ScotiabankTarget raisedBuy$33 → $35
Nov 4CitigroupMaintainedHold$30
Loading…

Technical Analysis

PFE · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend

The stock is 4% below its 20 day and 1% below its 50 day average. It is 5% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $28.32, and the nearest resistance the Pivot at $28.49.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 2.4%/day
Key levels
$31.4452 week high+10.5%
$29.6820 day average+4.3%
$28.8250 day average+1.3%
$28.63Pivot R1+0.6%
$28.58Swing high (Aug 25)+0.4%
$28.49Pivot+0.1%
$28.46Last close
$28.32Pivot S1−0.5%
$27.64Swing low (Aug 31)−2.9%
$27.44100 day average−3.6%
$27.01200 day average−5.1%
$23.6252 week low−17.0%
Indicators
RSI (14)40.86Middle of its rangeNeutral
MACD-0.04Below its signal lineBearish
Stochastic8.9Near the bottom of its rangeOversold
ADX (14)21.2Weak trend
Williams %R-96.4Oversold below −80, overbought above −20Oversold
CCI (20)-148.6Oversold below −100, overbought above 100Oversold
Rate of change−5.1%Change over 10 sessionsBearish
ATR (14)$0.68Typical daily range, 2.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for PFE

What happened before

See how PFE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bearish1 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow PFE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How PFE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
3
Bullish
1
33%
Bearish
2
67%
Date span
Aug 31 – Nov 4
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
32
Notional
$34.4M
Largest print
$4.8M
Loading…

PFE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●1,329 buying vs 1,326 selling
  • ▼Held by funds -1.7 pts
  • ▲Funds holding +54
  • ▲Superinvestors: 3 added, 1 cut
  • ▼Put/call 0.62 to 1.21
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2,9042,850+1.9%
In funds' top 103421+61.9%
Held by funds66.2%67.8%−1.7 pts
New / increased229 / 1,100121 / 1,132+6.1%
Reduced / sold out1,194 / 1321,203 / 236−7.9%
Put/call ratio1.210.62+94.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See PFE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

PFE Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$3.3B
2.0% of value
Shares outstanding, 12 months
+0.2%
More shares
Last quarter
$1.4M
Sep 2026
Avg price paid, last quarter
$26.18
55K shares bought
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $268.9M
Dec 2023: $1.6M, average price $30.27Mar 2024: $268.9M, average price $27.67Jun 2024: $2.1M, average price $27.62Sep 2024: $2.8M, average price $29.16Dec 2024: $3.6M, average price $27.35Mar 2025: $244.7M, average price $26.24Jun 2025: $1.9M, average price $23.88Sep 2025: $1.7M, average price $24.54Dec 2025: $3.4M, average price $25.27Mar 2026: $179.5M, average price $27.07Jun 2026: $3.7M, average price $26.89Sep 2026: $1.4M, average price $26.18
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 3, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PFE is in one of them and how their past PFE trades turned out.

PFE in the AI portfolios
Loading…

PFE News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered PFE in an article yet. Here's the latest on the wider market.

PFE Congress Trades

All congress trades →
Trades, 12 months
33
Buys
17
52%
Sells
16
48%
People
11
Last filed Nov 5
Who traded PFE · since 2015
Latest 5 filings of 344
$15K – $50KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 25, 2026Filed Oct 7, 2026
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
$15K – $50KTraded Sep 4, 2026Filed Oct 7, 2026
$100K – $250KTraded Aug 21, 2026Filed Sep 22, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$15K – $50KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CABuy$1K – $15KSep 25, 2026Oct 7, 202612 d
Ro KhannaD · CABuy$1K – $15KSep 11, 2026Oct 7, 202626 d
Ro KhannaD · CASell$15K – $50KSep 4, 2026Oct 7, 202633 d
Donald J TrumpExecutive branchBuy$100K – $250KAug 21, 2026Sep 22, 202632 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Pfizer

Pfizer is a pharmaceutical and biotechnology company headquartered in New York. It researches, develops, makes and sells medicines and vaccines, including Eliquis, Comirnaty and Paxlovid, along with biosimilar versions of biologic medicines. Its work spans areas such as oncology and obesity. Its customers include pharmacy chains, wholesalers, healthcare providers, government payors and patients in markets around the world.

Headquarters
New York, NY
Founded
1849